BEDMINSTER, NJ – November 8, 2011 – Nautilus Neurosciences, Inc., a neurology-focused specialty pharmaceutical company headquartered in Bedminster, New Jersey, announced today that Peter A. Lankau has joined the company as Executive Chairman of the Board of Directors. Mr. Lankau will have an active role in the company and will focus primarily on business strategy…